31. January 2024 by

BMO Capital Starts Sarepta Therapeutics (SRPT) at Outperform, ‘DMD’s High Unmet Need Is All That Matters’

Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/BMO+Capital+Starts+Sarepta+Therapeutics+%28SRPT%29+at+Outperform%2C+%27DMD%27s+High+Unmet+Need+Is+All+That+Matters%27/22697519.html for the full story.

One Reply to “BMO Capital Starts Sarepta Therapeutics (SRPT) at Outperform, ‘DMD’s High Unmet Need Is All That Matters’”

Jefferson_I says:

13. July 2024 at 03:38

Very interesting subject, regards for posting.Raise your business

Reply

One Reply to “BMO Capital Starts Sarepta Therapeutics (SRPT) at Outperform, ‘DMD’s High Unmet Need Is All That Matters’”

Leave a Reply Cancel reply